IGFBP3/TMEM219 blockade with ecto-TMEM219 prevented the onset of diabetes in nearly 75% of treated mice (up to 80%), while only 25% of control mice were protected from diabetes in the untreated group (Fig. 5e). The gene discussed is TMEM219; the disease is diabetes mellitus.